MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor (Q36850845)
Jump to navigation
Jump to search
scientific article published on 26 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor |
scientific article published on 26 March 2013 |
Statements
1 reference
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor (English)
1 reference
Michael M Gottesman
1 reference
Robert W Robey
1 reference
Susan E Bates
1 reference
Richard L Piekarz
1 reference
Arup R Chakraborty
1 reference
Victoria L Luchenko
1 reference
Zhirong Zhan
1 reference
Jean-Pierre Gillet
1 reference
Andrew V Kossenkov
1 reference
Julia Wilkerson
1 reference
Louise C Showe
1 reference
Nathan L Collie
1 reference
26 March 2013
1 reference
1 reference
4115-4125
1 reference
Identifiers
1 reference
1 reference
1 reference